BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32862200)

  • 1. Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway.
    Yang YF; Chang YC; Jan YH; Yang CJ; Huang MS; Hsiao M
    Oncogenesis; 2020 Aug; 9(8):78. PubMed ID: 32862200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancer metastasis.
    Yang YF; Jan YH; Liu YP; Yang CJ; Su CY; Chang YC; Lai TC; Chiou J; Tsai HY; Lu J; Shen CN; Shew JY; Lu PJ; Lin YF; Huang MS; Hsiao M
    Am J Respir Crit Care Med; 2014 Sep; 190(6):675-87. PubMed ID: 25152164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation.
    Brusselmans K; Timmermans L; Van de Sande T; Van Veldhoven PP; Guan G; Shechter I; Claessens F; Verhoeven G; Swinnen JV
    J Biol Chem; 2007 Jun; 282(26):18777-85. PubMed ID: 17483544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.
    Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH
    Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway.
    Fong YC; Liu SC; Huang CY; Li TM; Hsu SF; Kao ST; Tsai FJ; Chen WC; Chen CY; Tang CH
    Lung Cancer; 2009 Jun; 64(3):263-70. PubMed ID: 18996613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer.
    Feng YH; Su YC; Lin SF; Lin PR; Wu CL; Tung CL; Li CF; Shieh GS; Shiau AL
    BMC Cancer; 2019 Aug; 19(1):791. PubMed ID: 31399076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
    Kang CG; Im E; Lee HJ; Lee EO
    Bioorg Med Chem Lett; 2017 May; 27(9):1914-1918. PubMed ID: 28359791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho-associated kinase signaling is required for osteopontin-induced cell invasion through inactivating cofilin in human non-small cell lung cancer cell lines.
    Kang CG; Han HJ; Lee HJ; Kim SH; Lee EO
    Bioorg Med Chem Lett; 2015 May; 25(9):1956-60. PubMed ID: 25817589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
    Cheng HC; Liu YP; Shan YS; Huang CY; Lin FC; Lin LC; Lee L; Tsai CH; Hsiao M; Lu PJ
    Carcinogenesis; 2013 Nov; 34(11):2452-9. PubMed ID: 23774402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
    Das R; Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
    Wu CY; Wu MS; Chiang EP; Wu CC; Chen YJ; Chen CJ; Chi NH; Chen GH; Lin JT
    Gut; 2007 Jun; 56(6):782-9. PubMed ID: 17148500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis.
    Sun BS; You J; Li Y; Zhang ZF; Wang CL
    Chin Med J (Engl); 2013; 126(9):1683-8. PubMed ID: 23652051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.
    Qin H; Wang R; Wei G; Wang H; Pan G; Hu R; Wei Y; Tang R; Wang J
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):525-534. PubMed ID: 29214433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAPK pathway and SIRT1 are involved in the down-regulation of secreted osteopontin expression by genistein in metastatic cancer cells.
    Khongsti K; Das KB; Das B
    Life Sci; 2021 Jan; 265():118787. PubMed ID: 33249095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the Therapeutic Potential of Squalene Synthase: Deciphering Its Biochemical Mechanism, Disease Implications, and Intriguing Ties to Ferroptosis.
    Picón DF; Skouta R
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of osteopontin in limited-stage small cell lung cancer patients and its mechanism.
    Liu F; Bai C; Guo Z
    Oncotarget; 2017 Sep; 8(41):70084-70096. PubMed ID: 29050263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin increases breast cancer cell sensitivity to specific signaling pathway inhibitors in preclinical models.
    Mutrie JC; Chambers AF; Tuck AB
    Cancer Biol Ther; 2011 Oct; 12(8):680-90. PubMed ID: 21795853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy.
    Cook AC; Chambers AF; Turley EA; Tuck AB
    J Biol Chem; 2006 Aug; 281(34):24381-9. PubMed ID: 16807238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers.
    Sakaguchi H; Fujimoto J; Hong BL; Tamaya T
    Cancer Lett; 2007 Mar; 247(1):98-102. PubMed ID: 16675104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and regulation of mammalian squalene synthase.
    Tansey TR; Shechter I
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):49-62. PubMed ID: 11111077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.